Ceribell Inc. has announced that it has filed complaints against Natus Medical Incorporated and its related subsidiaries, alleging patent infringement and unfair competition. The complaints focus on six patents related to important features of Ceribell's EEG headband and electrode design, which are part of its point-of-care electroencephalography (EEG) technology. Ceribell has filed a complaint with the U.S. District Court in Delaware and has also approached the U.S. International Trade Commission, seeking an investigation and an exclusion order to prevent the importation of any infringing Natus products into the United States. Jane Chao, Ph.D., co-founder and CEO of Ceribell, emphasized the company's commitment to protecting its intellectual property and ensuring fair competition in the market.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.